Heartflow Reports Strong Q4 & FY25 Results, Guides for Continued Growth in 2026
HTFL sits 27% above its 52-week low of $20.13 on elevated volume (2.2× avg).
Summary
Heartflow, Inc. announced robust fourth quarter and full-year 2025 financial results, featuring 40% revenue growth and expanded gross margins, alongside optimistic 2026 guidance and increased insurance coverage for its Plaque Analysis.
Key Events · Earnings and Guidance · HTFL
-
Strong Revenue Growth Reported
Total revenue increased by 40% year-over-year for both the fourth quarter and full year 2025, reaching $49.1 million and $176.0 million, respectively.
-
Gross Margin Expansion
GAAP gross margin improved to 79.5% in Q4 2025, up from 75.0% in the prior year period, driven by increased volume and AI efficiency initiatives.
-
Expanded Insurance Coverage for Plaque Analysis
Aetna began coverage of Heartflow Plaque Analysis, increasing total U.S. covered lives for the product to approximately 75%.
-
Positive 2026 Annual Guidance
The company projects 2026 total revenue between $218 million and $222 million (24% to 26% growth year-over-year) and non-GAAP gross margin of 80% to 81%.
Analysis · HTFL · Industrial Applications And Services
Heartflow, Inc. delivered robust financial results for the fourth quarter and full year 2025, marked by significant revenue growth and expanding gross margins. The 40% year-over-year revenue increase for both periods demonstrates strong market adoption of its AI-powered coronary artery disease technology. A key development is Aetna's new coverage for Heartflow Plaque Analysis, which substantially expands the addressable market by bringing total U.S. covered lives to approximately 75%. This expanded coverage is a significant catalyst for future revenue growth and market penetration. While the company continues to report operating losses, the non-GAAP net operating loss improved year-over-year in Q4, indicating progress towards profitability. The optimistic 2026 guidance, projecting 24-26% revenue growth and further gross margin expansion, reinforces confidence in the company's trajectory and business fundamentals.
How filings like this one have moved
In the 30 days to Sep 15, 2026, 35.6% of the 1100 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.43%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, HTFL was trading at $25.48 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $2.2B. The 52-week trading range was $20.13 to $41.22. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.